Alector (ALEC) Cash from Financing Activities (2018 - 2026)
Alector (ALEC) reported Cash from Financing Activities of $25000.0 for Q1 2026, down 99.54% quarter-over-quarter from $5.4 million in Q4 2025.
Alector (ALEC) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Cash from Financing Activities data on file, last reported at $25000.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $25000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $20.2 million (up 94.02% YoY), and the FY2025 annual result was $20.2 million, down 75.21% from the prior year.
- Cash from Financing Activities eased to $25000.0 in Q1 2026 per ALEC's latest filing, from $5.4 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $71.1 million in Q1 2024 and troughed at $25000.0 in Q1 2026.
- A 5-year average of $7.8 million and a median of $893500.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities slumped 96.7% in 2022, then surged 6490.18% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $636000.0 in 2022, then decreased by 7.23% to $590000.0 in 2023, then surged by 1558.98% to $9.8 million in 2024, then sank by 44.91% to $5.4 million in 2025, then sank by 99.54% to $25000.0 in 2026.
- Business Quant data shows ALEC's Cash from Financing Activities at $25000.0 in Q1 2026, $5.4 million in Q4 2025, and $14.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 5.39 Mn |
| Dec 31, 2025 | 5.39 Mn |
| Sep 30, 2025 | 14.70 Mn |
| Sep 30, 2025 | 14.70 Mn |
| Jun 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Dec 31, 2024 | 9.79 Mn |
| Dec 31, 2024 | 9.79 Mn |
| Jun 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 71.11 Mn |
| Mar 31, 2024 | 71.11 Mn |
| Dec 31, 2023 | 590,000.00 |
| Dec 31, 2023 | 590,000.00 |
| Jun 30, 2023 | 881,000.00 |
| Jun 30, 2023 | 881,000.00 |
| Mar 31, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.08 Mn |